Gavin Wood, CFO of Adaptimmune Therapeutics PLC (ADAPY), made one open market sale of common shares in the last 365 days, totaling $950.40. His most recent sale occurred on September 2, 2025. These sales rank 11,549th among 11,678 individual insiders, where the average sale amount is about $8.6 million across roughly 6.4 transactions. Wood has no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 2, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Wood Gavin | Chief Financial Officer | S | Ordinary Shares with a nominal value of GBP0.001 per share | 96000 | $0.01 | 0.0000 | 1,584,522,868 | 100.00% | 0.01% |
| Jan. 15, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Wood Gavin | Chief Financial Officer | A | Option to purchase Ordinary Shares | 2544432 | $0.00 | 2,544,432.0000 | 1,206,440,978 | 9999.99% | 0.21% |
| Jan. 15, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Wood Gavin | Chief Financial Officer | A | Option to purchase Ordinary Shares | 565416 | $0.00 | 565,416.0000 | 1,206,440,978 | 9999.99% | 0.05% |